CD19 Target-Engineered T-Cells Accumulate at Tumor Lesions in Human B-Cell Lymphoma Xenograft Mouse Models
Biochemical and Biophysical Research Communications - United States
doi 10.1016/j.bbrc.2013.07.030
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2013
Authors
Publisher
Elsevier BV